Research Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Principal Investigator 
Jan P. Dutz

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT03813160
Status 
Recruiting
Study Start/End 
Feb 11, 2020 to Dec 31, 2021
Locations 
Vancouver General Hospital
Name/Title 
Jaspal Mor, Study Coordinator
Phone 
604-875-5296
Email Address 
jaspal.mor@ubc.ca
Purpose of Study 

The purpose of this study is to evaluate the efficacy and safety of lenabasum for the treatment of dermatomyositis.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.